These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

62 related items for PubMed ID: 59682

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Biology of the human myeloma cell population. I.Macromolecular characteristics.
    Hulin N, Boccadoro M, Masera P, Pileri A.
    Ric Clin Lab; 1978; 8(1-2):39-48. PubMed ID: 705177
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [In vitro study of the RNA, protein and hemoglobin synthesis by erythroid cells of human bone marrow with the aid of H3-uridine, H3-glycine and H3-leucine].
    Plotkin VIa.
    Lab Delo; 1973; 12():717-9. PubMed ID: 4133150
    [No Abstract] [Full Text] [Related]

  • 6. The effect of uremia on the incorporation of isotopically labeled precursors into DNA, RNA and protein by bone marrow cells in vitro.
    Topilow AA, Da Costa M, Rothenberg SP.
    Clin Nephrol; 1973; 1(6):361-6. PubMed ID: 4786575
    [No Abstract] [Full Text] [Related]

  • 7. [Treatment of Kahler's disease].
    Foa J, Carcassonne Y.
    Sem Hop; 1976 Jan 16; 52(3):165-71. PubMed ID: 186874
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Various immunologic indicators of cytostatic therapy in patients with malignant lymphoproliferative processes].
    Sakalová A, Drobná V, Hrubisková D.
    Vnitr Lek; 1977 Jun 16; 23(7):681-7. PubMed ID: 331664
    [No Abstract] [Full Text] [Related]

  • 10. [Chemotherapy of multiple bone myeloma. Historical and present day aspects. (Second part) (author's transl)].
    Bataille R, Morlock G, Rosenberg F, Sany J, Serre H.
    Sem Hop; 1977 Jun 16; 55(31-32):1377-82. PubMed ID: 228415
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The effect of erythropoietin and erythroid hyperplasia on the response of rabbit bone marrow to actinomycin D.
    Hershko C, Izak G, Schwartz R.
    Isr J Med Sci; 1971 Jun 16; 7(7):910-8. PubMed ID: 5098379
    [No Abstract] [Full Text] [Related]

  • 15. Induction of serum stimulation and plasma cell proliferation during chemotherapy of multiple myeloma.
    Karp JE, Burke PJ, Humphrey RL.
    Blood; 1977 Jun 16; 49(6):925-34. PubMed ID: 861376
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Treatment of multiple myeloma in remission with anticancer drugs having cell cycle specific characteristics.
    Alberts DS, Durie BG, Salmon SE.
    Cancer Treat Rep; 1977 Jun 16; 61(3):381-8. PubMed ID: 872138
    [Abstract] [Full Text] [Related]

  • 18. [Combined cytostatic treatment of solid tumours with cyclophosphamide (Endoxan), vincristine, methylaminopterin (Methotrexate) and 5-fluorouracil].
    Brincker H.
    Ugeskr Laeger; 1971 May 14; 133(19):926-9. PubMed ID: 5559763
    [No Abstract] [Full Text] [Related]

  • 19. The current status and future prospects of treatment for multiple myeloma.
    Durie BG, Salmon SE.
    Clin Haematol; 1982 Feb 14; 11(1):181-210. PubMed ID: 6176381
    [No Abstract] [Full Text] [Related]

  • 20. Glycogen in erythroid cells.
    Skinnider LF, Ghadially FN.
    Arch Pathol; 1973 Feb 14; 95(2):139-41. PubMed ID: 4509401
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.